Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

NCT07074327 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: VX-407
DRUG: LNG/EE
DRUG: NGM/EE
DRUG: NET/EE
DRUG: DRSP/EE

Sponsor

Vertex Pharmaceuticals Incorporated